Cargando…
Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa
The early onset and rapid progression of cutaneous squamous cell carcinoma (cSCC) leads to high mortality rates in individuals with recessive dystrophic epidermolysis bullosa (RDEB). Currently, the molecular mechanisms underlying cSCC development in RDEB are not well understood and there are limited...
Autores principales: | Rami, Avina, Łaczmański, Łukasz, Jacków-Nowicka, Jagoda, Jacków, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795642/ https://www.ncbi.nlm.nih.gov/pubmed/33383666 http://dx.doi.org/10.3390/ijms22010245 |
Ejemplares similares
-
Squamous cell carcinoma in a pregnant woman with recessive dystrophic epidermolysis bullosa
por: Lopes, Jorge, et al.
Publicado: (2020) -
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
por: Neumayer, Gernot, et al.
Publicado: (2023) -
TGFβ-signaling in Squamous Cell Carcinoma Occurring in Recessive Dystrophic Epidermolysis Bullosa
por: Knaup, Julia, et al.
Publicado: (2011) -
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
por: Diociaiuti, Andrea, et al.
Publicado: (2019) -
Photodynamic Therapy for Basal Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa
por: Lee, Myn Wee, et al.
Publicado: (2011)